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Background
Effective treatment of tinea pedis and onychomycosis is
crucial for patients with diabetes as these infections may
lead to foot ulcers and eventual lower limb amputation.
Although numerous studies have assessed the effective-
ness of antifungal drug and treatment regimens, most
exclude patients with diabetes and examine otherwise
healthy individuals. While these studies are useful,
results cannot necessarily be extrapolated to patients
with diabetes. The purpose of this study was to there-
fore identify the best evidence-based treatment options
for tinea pedis or onychomycosis in people with
diabetes.
Methods
The question for this systemic review was what evidence
is there for antifungal treatment interventions for adults
with tinea pedis and/or onychomycosis in people with
diabetes. A systematic literature search of four electronic
databases (Scopus, EbscoHost, Ovid, Web of Science)
was undertaken using the search terms ‘‘onychomycosis”
or “tinea pedis” or “athlete’s foot” or “tinea unguium”
and ‘‘diab*’’ and “treat*” (15/10/10). No language or date
restrictions were set. Studies that examined the efficacy
and/or safety of treatment options for people with dia-
betes were included in this study.
Results
Preliminary results of this study indicate a scarcity of
studies specifically investigating antifungal treatments of
tinea pedis and onychomycosis in patients with diabetes.
Of the seven studies identified to date, all examined the
efficacy and/or safety of antifungal agents for the treat-
ment of onychomycosis. Of the antifungal agents
assessed, topical ciclopirox nail lacquer, oral terbinafine
and oral itraconazole were found both safe and effective
for treatment. To date, no studies investigating the
treatment for tinea pedis have been identified. Although
suggestions that combination drug therapy and physical
debridement are effective treatment strategies, studies to
confirm these suggestions have never been conducted.
Conclusions
The results of this study indicate further research is
needed to determine the best evidence-based treatment
options for tinea pedis and onychomycosis in patients
with diabetes. Areas for future research include studies
that investigate the treatment for tinea pedis, the effec-
tiveness of other antifungal drugs and dosing regimens,
combination drug therapy and physical debridement.
Such research may identify more effective treatment
options that may reduce the incidence of diabetic foot
ulcers and associated complications.
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